Adam J. Gadzinski, MD, MS, on Up-and-Coming Research for Urologic Oncology
The expert in urologic oncology spoke about new innovations that he believes will aid in treating patients with urologic cancers.
Adam J. Gadzinski, MD, MS, on Next Steps for Assessing the Impact of Telemedicine on Patient-Reported Outcomes
An expert in urologic oncology seeks to answer further questions regarding the use of telemedicine for this patient population.
Adam J. Gadzinski, MD, MS, on the Limitations of a Study Assessing the Impact of Telemedicine on Patient-Reported Outcomes
Study results revealed the impact of a rurally focused telemedicine program on patient outcomes.
Adam J. Gadzinski, MD, MS, on Study Results Assessing the Impact of Telemedicine on Patient-Reported Outcomes
The study was designed to determine the impact of a rurally focused telemedicine program on patient outcomes.
Adam J. Gadzinksi, MD, MS, on the Impact of Telemedicine on Patient-Reported Outcomes
The study assessed the impact of a rurally focused telemedicine program on patient outcomes in the urologic oncology outpatient clinic at the University of Washington Medical Center.
Adam J. Gadzinski, MD, MS, on the Design of a Study Assessing Impact of Telemedicine on Patient-Reported Outcomes
The study sought to determine the impact of a rurally focused telemedicine program on patient outcomes.
Adam J. Gadzinski, MD, MS, on the Research Coming Out of SUO This Year
Gadzinski spoke about the most exciting aspect of the research coming out of the 21st Annual Meeting of the Society of Urologic Oncology (SUO).
